Telesis Bio Shifts Focus to AI-Native Drug Discovery, Launches New Website
Trendline

Telesis Bio Shifts Focus to AI-Native Drug Discovery, Launches New Website

What's Happening? Telesis Bio, a San Diego-based DNA synthesis company, has announced a strategic shift to focus on AI-native drug discovery. The company will now supply on-premises DNA synthesis infrastructure to AI discovery teams, aiming to accelerate the design-build-test-learn cycle in therapeu
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.